13F-HR filed by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P. filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:31:36 UTC, with 92 holding rows worth $9,969,410,191.
- Accession
- 0001104659-26-128411
- Filer
- CIK 1346824
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 92 entries on the cover page, a total value of $9,969,410,191 stated on the cover page (in dollars after the unit check, H1), rows summing to $9,969,410,191 with VALUE read as dollars as filed, 13F file number 028-12884. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 10,281,496 | $2,342,433,234 | dollars as filed | |
| PARABILIS MEDICINES INC COM | 698955101 | Stock | 29,177,964 | $942,156,458 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 11,474,599 | $652,904,683 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 6,666,837 | $634,782,885 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 8,392,730 | $340,744,838 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 12,198,625 | $266,783,929 | dollars as filed | |
| FREENOME INC | 35661P100 | COMMON STOCK | 15,367,270 | $242,034,503 | dollars as filed | |
| HEMAB THERAPEUTICS HLDGS INC | 423494103 | COM SHS | 7,808,627 | $240,818,057 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 9,550,191 | $232,260,645 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 5,502,858 | $215,326,834 | dollars as filed | |
| SPYGLASS PHARMA INC | 85220G109 | COMMON STOCK | 8,021,117 | $208,549,042 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 11,189,693 | $193,357,895 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 7,692,750 | $193,318,808 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 2,450,221 | $160,391,467 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 30,435,190 | $148,219,375 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 7,255,993 | $135,034,030 | dollars as filed | |
| ARTIVA BIOTHERAPEUTICS INC | 04317A107 | COM | 18,489,293 | $131,643,766 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 5,274,274 | $131,593,136 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 1,554,597 | $129,482,384 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 4,279,341 | $124,528,823 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 10,130,130 | $116,192,591 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 1,030,058 | $101,996,343 | dollars as filed | |
| Wave Life Sciences Inc. | 94352A104 | COM | 26,975,505 | $99,809,369 | dollars as filed | |
| Latigo Biotherapeutics, Inc. | 517954103 | Common Stock, par value $0.0001 per share | 5,302,933 | $88,558,981 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 12,036,126 | $87,021,191 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 4,503,882 | $85,934,069 | dollars as filed | |
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 2,208,604 | $84,766,222 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 3,609,007 | $84,739,484 | dollars as filed | |
| Obsidian Therapeutics, Inc. | 67448A106 | Common Stock, $0.0001 par value per share | 5,957,103 | $81,791,024 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 2,815,543 | $74,161,403 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 5,049,779 | $72,262,337 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 12,723,026 | $66,923,117 | dollars as filed | |
| SANA BIOTECHNOLOGY INC | 799566104 | COM | 18,750,000 | $54,656,250 | dollars as filed | |
| MONOPAR THERAPEUTICS INC | 61023L207 | COMMON STOCK | 667,207 | $53,156,382 | dollars as filed | |
| GERON CORP | 374163103 | COM | 42,754,145 | $52,587,598 | dollars as filed | |
| DAMORA THERAPEUTICS INC | G2646Y104 | COMM STK | 2,399,702 | $51,065,659 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 20,064,545 | $48,556,199 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 10,860,977 | $46,810,811 | dollars as filed | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 20,992,669 | $46,603,725 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J309 | SPONSORED ADS | 3,657,644 | $43,013,893 | dollars as filed | |
| AGENUS INC | 00847G804 | COM NEW | 4,122,000 | $40,931,460 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 9,445,039 | $39,102,461 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 6,456,234 | $33,959,791 | dollars as filed | |
| SCRIBE THERAPEUTIC COM | 811033109 | COM | 1,802,178 | $33,169,086 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 17,754,430 | $30,360,075 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 3,494,638 | $28,865,710 | dollars as filed | |
| KORSANA BIOSCIENCES INC | 23255M303 | COMMON STOCK | 892,743 | $28,567,776 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 3,014,183 | $28,544,313 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 10,805,129 | $28,309,438 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 8,194,779 | $27,288,614 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 1,835,542 | $25,789,365 | dollars as filed | |
| PRELUDE THERAPEUTICS INC | 74065P101 | CMN | 6,475,882 | $25,320,699 | dollars as filed | |
| ACRIVON THERAPEUTICS INC | 004890109 | CMN | 12,229,396 | $25,070,262 | dollars as filed | |
| ASSEMBLY BIOSCIENCES INC | 045396207 | COMMON STOCK | 1,020,410 | $23,969,431 | dollars as filed | |
| EDITAS MEDICINE INC | 28106W103 | COM | 8,889,000 | $22,844,730 | dollars as filed | |
| Q32 BIO INC | 746964105 | Common Stock | 2,332,457 | $19,289,419 | dollars as filed | |
| ANTERIS TECHNOLOGIES GLOBAL | 03675P102 | COMMON STOCK | 2,474,076 | $19,223,571 | dollars as filed | |
| Electra Therapeutics, Inc. | 284825106 | Common Stock, $0.0001 par value per share | 1,692,965 | $19,045,856 | dollars as filed | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 6,500,000 | $18,590,000 | dollars as filed | |
| BENITEC BIOPHARMA INC | 08205P209 | COMMON STOCK | 1,850,000 | $18,500,000 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 13,011,849 | $18,086,470 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 1,800,000 | $17,784,000 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 5,000,000 | $16,900,000 | dollars as filed | |
| LENZ THERAPEUTICS INC | 52635N103 | COM | 4,178,823 | $16,046,680 | dollars as filed | |
| AURA BIOSCIENCES INC | 05153U107 | COMMON STOCK | 2,500,000 | $15,700,000 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 1,000,000 | $15,330,000 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 6,970,000 | $14,323,350 | dollars as filed | |
| ENTERA BIO LTD | M40527109 | SHS | 4,901,960 | $14,264,704 | dollars as filed | |
| SEAPORT THERAPEUTICS INC | 81221K108 | COMMON STOCK | 700,000 | $14,119,000 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 4,401,500 | $13,952,755 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 5,598,200 | $13,939,518 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 159,278 | $13,615,083 | dollars as filed | |
| HELIX ACQUISITION CORP III | G4444S107 | USD CL A ORD SHS | 1,250,000 | $13,275,000 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 265,000 | $13,202,300 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 1,914,788 | $13,058,854 | dollars as filed | |
| Braveheart Bio Inc | 10567X101 | COM | 565,000 | $11,413,000 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 3,998,333 | $10,895,457 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 7,124,116 | $9,617,557 | dollars as filed | |
| INOVIO PHARMACEUTICALS I | 45773H409 | COMMON STOCK | 7,220,384 | $8,808,868 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 1,864,176 | $7,195,719 | dollars as filed | |
| RANI THERAPEUTICS HLDGS INC | 753018100 | CMN | 8,500,000 | $6,723,500 | dollars as filed | |
| ADICET BIO INC | 007002207 | COM NEW | 932,624 | $6,658,935 | dollars as filed | |
| TCGX ACQUISITION CORP | G8708J109 | COM | 500,000 | $6,255,000 | dollars as filed | |
| FAETH THERAPEUTICS INC | 81728A207 | COM NEW | 205,060 | $6,098,484 | dollars as filed | |
| JATT II ACQUISITION CORP | G50765109 | ORD SHS | 500,000 | $5,622,500 | dollars as filed | |
| JATT III ACQUISITION CORP | G5080G109 | COM | 450,000 | $4,959,000 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 333,333 | $4,216,662 | dollars as filed | |
| AMANAT ACQUISITION CORP | G0375M101 | CL A ORD | 375,000 | $4,005,000 | dollars as filed | |
| EQUILLIUM INC | 29446K106 | COM | 2,317,741 | $3,766,329 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367201 | COMMON STOCK | 210,934 | $3,398,147 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 73,607 | $1,913,782 | dollars as filed | |
| PALATIN TECHNOLOGIES INC | 696077601 | COM NEW | 62,124 | $551,040 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-26-128411 | this filing | 2026-11-16 |